Skip to main content

Coronavirus: Ivermectin

Question for Department of Health and Social Care

UIN 135832, tabled on 11 January 2021

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of prescribing ivermectin for reducing the (a) transmission or (b) severity of covid-19.

This answer is the replacement for a previous holding answer.

Answered on

25 January 2021

The Therapeutics Taskforce is continuing to monitor any new, high quality evidence on COVID-19 therapeutics and has been following recent findings on ivermectin.

The Department has monitored a collection of small studies which have now completed and provided some positive signals on the use of ivermectin as a treatment for COVID-19. This is a promising step. However, larger-scale studies are still needed to confirm the effectiveness and safety of this treatment. The Therapeutics Taskforce is aware that several more studies into ivermectin are set to conclude in the next few months and will continue to monitor these ongoing trials to assess the evidence available on whether ivermectin reduces transmission and/or severity of COVID-19. The Department and its arm’s length bodies are prepared to act rapidly should any trial readouts prove positive at a greater scale.

Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.